End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
180 CZK | 0.00% | +4.65% | -26.83% |
2020 | Pilulka Lekarny has completed an IPO in the amount of CZK 307.41696 million. | CI |
2020 | Pilulka Lekarny has filed an IPO. | CI |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | - | - |
Enterprise Value (EV) 1 | - | - |
P/E ratio | - | -25.2 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | - | 11.7 x |
Nbr of stocks (in thousands) | - | - |
Reference price 2 | 1,685 | 650.0 |
Announcement Date | 04/04/23 | 04/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net sales 1 | 2,380 | 2,447 |
EBITDA 1 | 8.327 | -29.82 |
EBIT 1 | -13.99 | -47.67 |
Operating Margin | -0.59% | -1.95% |
Earnings before Tax (EBT) 1 | -24.68 | -64.01 |
Net income 1 | -25.5 | -64.94 |
Net margin | -1.07% | -2.65% |
EPS | - | -25.76 |
Free Cash Flow | - | -22.49 |
FCF margin | - | -0.92% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 04/04/23 | 04/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 71.6 | 20.7 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -22.5 |
ROE (net income / shareholders' equity) | - | -38.3% |
ROA (Net income/ Total Assets) | - | -4.99% |
Assets 1 | - | 1,302 |
Book Value Per Share | - | 55.60 |
Cash Flow per Share | - | 8.200 |
Capex 1 | 82.1 | 76.8 |
Capex / Sales | 3.45% | 3.14% |
Announcement Date | 04/04/23 | 04/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-26.83% | 21.07M | |
-20.84% | 12.04B | |
-23.82% | 6.52B | |
+15.41% | 6.44B | |
-10.55% | 6.15B | |
-2.48% | 4.63B | |
+60.00% | 4.62B | |
-6.67% | 3.93B | |
-10.60% | 3.49B | |
-5.88% | 3.05B |
- Stock Market
- Equities
- PINK Stock
- Financials Pilulka Lékárny